Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection
- 1 July 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 105 (1) , 27S-31S
- https://doi.org/10.1016/s0002-9343(98)00208-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Reversal of Left Ventricular Hypertrophy in Hypertensive PatientsAmerican Journal of Hypertension, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Clinical applications of angiotensin-converting enzyme inhibitorsThe American Journal of Medicine, 1984